M. C. de A. Ramos, “Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation”, Rev. saúde pública, vol. 52, p. 94, Nov. 2018, doi: 10.11606/S1518-8787.2018052000643.